New Leaf Venture Partners

New Leaf Venture Partners

New York City, New Yorknlvpartners.com

Overview

New Leaf Venture Partners is an early and growth-stage investor exclusively focused on healthcare technology. They invest across four sectors of healthcare technology: biopharmaceuticals, information convergence, medical devices, and life science tools. In Biopharmaceuticals, they invest from seed (creation) stage through to IPO and beyond. In Information Convergence (which includes healthcare IT, tools, and diagnostics) they invest from early stages through to companies with revenues of $100m+. They have a similar approach in Medical Devices and Life Sciences.

Year Founded

2005

AUM

$580M

Portfolio Companies

21

Investments

CompanyDateStageLead
BrightInsightJan 2026VC RoundCo-investor
Electra TherapeuticsOct 2025Series CCo-investor
AbcuroFeb 2025Series CCo-investor
TruverisMay 2024Series ELead
Qlaris BioApr 2024Series BLead

Key People

Linda Ledecky

Investing Partner And Vice President Of Corporate Development

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded2005
AUM$580M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.